RALTEGRAVIR for Hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 4,566 adverse event reports in the FDA FAERS database where RALTEGRAVIR was used for Hiv infection.
Most Reported Side Effects for RALTEGRAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 1,033 | 12.0% | 134 | 118 |
| Maternal exposure during pregnancy | 726 | 8.4% | 21 | 70 |
| Exposure during pregnancy | 700 | 8.1% | 23 | 86 |
| Drug interaction | 552 | 6.4% | 104 | 131 |
| Virologic failure | 517 | 6.0% | 8 | 37 |
| Depression | 482 | 5.6% | 101 | 121 |
| Death | 431 | 5.0% | 430 | 44 |
| Pathogen resistance | 425 | 4.9% | 2 | 30 |
| Drug resistance | 388 | 4.5% | 99 | 54 |
| No adverse event | 339 | 3.9% | 1 | 2 |
| Treatment failure | 290 | 3.4% | 105 | 12 |
| Viral mutation identified | 284 | 3.3% | 2 | 5 |
| Premature baby | 252 | 2.9% | 31 | 21 |
| Diarrhoea | 206 | 2.4% | 14 | 61 |
| Abortion spontaneous | 200 | 2.3% | 34 | 42 |
Other Indications for RALTEGRAVIR
Product used for unknown indication (1,376)
Antiretroviral therapy (353)
Prophylaxis against hiv infection (155)
Maternal exposure timing unspecified (112)
Hiv test positive (77)
Acquired immunodeficiency syndrome (72)
Hiv-2 infection (50)
Foetal exposure during pregnancy (47)
Prophylaxis (39)
Hepatitis c (37)
Other Drugs Used for Hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (27,672)
TENOFOVIR DISOPROXIL (19,662)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (15,794)
LAMIVUDINE (8,963)
DOLUTEGRAVIR (7,207)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (6,874)
RITONAVIR (6,739)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (5,840)
EFAVIRENZ (5,261)
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (4,854)